Intense thinking for API manufacture
How to drive process intensification, continuous manufacturing, and biocatalysis into API processes. Delivering improved control, efficiency and compliance whilst reducing the carbon footprint of medicines manufacture whilst enhancing national security and resilience.
FACILITATED BY
CLIVE BADMAN OBE | Executive Director | University of Strathclyde
PANELLISTS INCLUDE
MARK TALFORD | Deputy Challenge Director | Medicines Manufacturing
SALVATORE MASCIA | Founder & Chief Executive Officer | CONTINUUS Pharmaceuticals
RAJEEV BUDHDEV | Executive Vice President & Head – API R&D | Dr. Reddy’s Laboratories
RUTH HARDY | Director Chemical Research | Pfizer
MIKE GIBSON | Chief Technical Officer | Sterling Pharma Solutions